Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Last updated: September 30, 2017
Sponsor: Chengdu PLA General Hospital
Overall Status: Trial Status Unknown

Phase

N/A

Condition

Joint Injuries

Arthritis And Arthritic Pain

Musculoskeletal Diseases

Treatment

N/A

Clinical Study ID

NCT02257047
RYR20140104
  • Ages 18-75
  • All Genders

Study Summary

To evaluate the effect of red yeast rice on subclinical atherosclerosis in patients with rheumatoid arthritis

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with a definite diagnose of rheumatoid arthritis(RA) were included if theymet the classification criteria for RA established by the American RheumatismAssociation (ACR) and European League Against Rheumatism (EULAR) in 2010

  • aged from 18 to 75 years

  • without conflict to the written, informed consent signed prior to the enrollment

  • no severe hepatic or renal disorders

  • no known carotid artery stenosis

  • no coagulation disorders

  • no hypertension

Exclusion

Exclusion Criteria:

  • being in pregnancy, lactation period or under a pregnancy plan

  • being allergic to the test drug

  • not compatible for the trial medication

  • without full legal capacity

Study Design

Total Participants: 120
Study Start date:
October 01, 2014
Estimated Completion Date:
March 31, 2019

Connect with a study center

  • General Hospital of Chengdu Military Area Command PLA

    Chengdu, Sichuan 610083
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.